Traumatic Arthritis
54
6
19
17
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.5%
10 terminated out of 54 trials
63.0%
-23.5% vs benchmark
6%
3 trials in Phase 3/4
59%
10 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (54)
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Cemented vs Cementless Persona Keel RCT
Persona Partial Knee Clinical Outcomes Study
Efficacy of Intra-articular Collagen Injection in Patients With Knee Joint Pain Compared to Normal Saline Injection
Perform® Humeral System - Fracture Study (PFX)
The Post-marketing Surveillance to Evaluate the Efficacy of CHONDRON (Autologous Cultured Chondrocyte) by Arthroscopy
The Post-marketing Surveillance to Evaluate the Efficacy and Safety of a CHONDRON (Autologous Cultured Chondrocyte)
Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
Persona Total Knee Arthroplasty Outcomes Study
Pyrocarbon Clinical Follow-up Study
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
Zimmer POLAR Persona - TKA (EMEA Study)
Persona Ti-Nidium Post-Market Clinical Follow-up
The Medacta International SMS Post-Marketing Surveillance Study
The Medacta Quadra-P Anteverted Study
The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Post Market Clinical Follow-Up KeriFlex®